Childhood asthma
Conditions
Interventions
experimental group:Compound Glycyrrhizin Tablets
control group:placebo
Sponsors
University of Chinese Acadaemy of Sciences Shenzhen Hosptial
Eligibility
Sex/Gender
All
Age
3 Years to 14 Years
Inclusion criteria
Inclusion criteria: (1) Patients who meet the diagnostic criteria: the diagnostic and grading standards for bronchial asthma in the 8th edition of Zhufutang Practical Pediatrics; (2) Patients aged 3 - 14 years old; gender: male to female ratio 1: 1; (3) Condition: Moderate; (4) Those who voluntarily participated in this study, signed an informed consent, and agreed to abide by the treatment prescribed in this study.
Exclusion criteria
Exclusion criteria: (1) Combined with cardiopulmonary and other serious diseases and mental disorders; (2) Poor compliance and unable to cooperate with oral medication; (3) Those who have used drugs in the treatment group within 2 weeks before enrollment; (4) Those who are known to be allergic to the drugs and their ingredients used in this test; (5) Those who require oral or intravenous glucocorticosteroids due to their condition; (6) Those who are participating in other drug trials or have participated in other clinical trials within 4 weeks before enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma control rate;Expression of Th17 cells in venous blood;Expression of Treg cells in venous blood;Blood; | — |
Countries
China
Contacts
Public ContactJiahua Li
University of Chinese Acadaemy of Sciences Shenzhen Hosptial
Outcome results
None listed